Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by DavidRosenbergon Mar 02, 2023 5:01pm
52 Views
Post# 35316150

RE:Kevin Harrington’s involvement with Celsius holdings

RE:Kevin Harrington’s involvement with Celsius holdings
Celsius Holdings, Inc. is a publicly traded company that reports its financial results to the Securities and Exchange Commission (SEC). Here is a brief overview of the company's financials based on its most recent quarterly report as of September 30, 2021:
 
Revenue: For the third quarter of 2021, Celsius reported net revenues of $111.1 million, an increase of 16.6% compared to the same period in the previous year.
 
Gross Profit: Gross profit for the quarter was $44.5 million, an increase of 15.3% compared to the third quarter of 2020. Gross profit margin was 40.0% for the quarter, down slightly from 40.1% in the previous year.
 
Net Income: Celsius reported net income of $9.3 million for the quarter, compared to a net loss of $0.2 million in the same period in the previous year. The increase in net income was driven by strong revenue growth and improved gross profit margins.
 
Earnings Per Share: Earnings per share for the quarter were $0.17 per share, compared to a loss of $0.00 per share in the third quarter of 2020.
 
Cash and Equivalents: Celsius Holdings had cash and equivalents of $88.4 million as of September 30, 2021, compared to $41.3 million as of December 31, 2020. This increase was primarily due to the issuance of new common stock in a public offering in July 2021.
 
Overall, Celsius Holdings has reported strong financial results in recent quarters, with solid revenue growth and improved profitability. The company's balance sheet also appears to be strong, with a significant cash position that could support future growth initiatives.
<< Previous
Bullboard Posts
Next >>